Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Newly Diagnosed Glioblastoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchStudy completedNCT01165632
What this trial is testing

Fluorine F 18 Fluorodopa-Labeled PET Scan in Planning Surgery and Radiation Therapy in Treating Patients With Newly Diagnosed High- or Low-Grade Malignant Glioma

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligodendroglioma+13 more
Mayo Clinic 24
Large-scale testing (Phase 3)Study completedNCT00017147
What this trial is testing

S0001 RT and Carmustine With or Without O6BG in Patients With New Glioblastoma Multiforme or Gliosarcoma

Who this might be right for
Malignant Neoplasms of Eye, Brain and Other Parts of Central Nervous System
SWOG Cancer Research Network 183
Testing effectiveness (Phase 2)WithdrawnNCT00005083
What this trial is testing

Functional Magnetic Resonance Imaging and 1H-Nuclear Magnetic Resonance Spectroscopic Imaging in Treating Patients With Newly Diagnosed Brain Tumors

Who this might be right for
Brain and Central Nervous System Tumors
Jonsson Comprehensive Cancer Center
Not applicableStudy completedNCT00002485
What this trial is testing

Development of Strategies to Increase Enrollment in Clinical Trials for Children With Cancer

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+8 more
Children's Oncology Group 359
Not applicableTemporarily pausedNCT05695976
What this trial is testing

GRETeL: Tumor Response to Standard Radiotherapy and TMZ Patients With GBM

Who this might be right for
GlioblastomaGlioma, Malignant
Duke University 100
Testing effectiveness (Phase 2)Study completedNCT00082797
What this trial is testing

High-Dose Methotrexate and Leucovorin in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Eastern Cooperative Oncology Group 36
Testing effectiveness (Phase 2)UnknownNCT04614493
What this trial is testing

Innovative SonoCloud-9 Device for Blood Brain Barrier Opening in First Line Temozolomide Glioblastoma Patients.

Who this might be right for
Initial Radiological Diagnosis Eligible for Tumor ResectionInitial Radiological Diagnosis Compatible With Newly Diagnosed Glioblastoma (IDH Wild-type)Eligible for the Standard of Care Including Concurrent Temoradiation and Adjuvant Temozolomide
Assistance Publique - Hôpitaux de Paris 66
Testing effectiveness (Phase 2)UnknownNCT01124240
What this trial is testing

Temozolomide and Procarbazine With Cilengitide for Patients With Glioblastoma Multiforme Without Methylation of the MGMT Promoter Gene

Who this might be right for
Newly Diagnosed Non Methylated Glioblastoma Multiforme Grade 4
Northern Sydney and Central Coast Area Health Service 48
Early research (Phase 1)Ended earlyNCT02510950
What this trial is testing

Neoepitope-based Personalized Vaccine Approach in Patients With Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma MultiformeAstrocytoma, Grade IV
Washington University School of Medicine 1
Testing effectiveness (Phase 2)Study completedNCT00028678
What this trial is testing

Dalteparin and Radiation Therapy in Treating Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Eastern Cooperative Oncology Group 45
Testing effectiveness (Phase 2)Study completedNCT03466450
What this trial is testing

Glasdegib (PF-04449913) With Temozolomide Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma
Grupo Español de Investigación en Neurooncología 75
Testing effectiveness (Phase 2)Study completedNCT03746080
What this trial is testing

Whole Brain Radiation Therapy With Standard Temozolomide Chemo-Radiotherapy and Plerixafor in Treating Patients With Glioblastoma

Who this might be right for
GlioblastomaGlioblastoma With Primitive Neuronal ComponentGliosarcoma+2 more
Lawrence D Recht 21
Early research (Phase 1)Study completedNCT00089427
What this trial is testing

IL13-PE38QQR Infusion After Tumor Resection, Followed by Radiation Therapy With or Without Temozolomide in Patients With Newly Diagnosed Malignant Glioma

Who this might be right for
Glioblastoma MultiformeAnaplastic AstrocytomaOligoastrocytoma
INSYS Therapeutics Inc 24
Not applicableWithdrawnNCT04926168
What this trial is testing

6 Months Adjuvant Temozolomide (TMZ) vs No Adjuvant TMZ in Newly Diagnosed MGMT Methylated Glioblastoma (GBM)

Who this might be right for
MGMT-Methylated Glioblastoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Testing effectiveness (Phase 2)Study completedNCT03158389
What this trial is testing

NCT Neuro Master Match - N²M² (NOA-20)

Who this might be right for
Glioblastoma, Adult
University Hospital Heidelberg 228
Testing effectiveness (Phase 2)Study completedNCT00004200
What this trial is testing

Prinomastat Plus Temozolomide Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Pfizer
Testing effectiveness (Phase 2)Ended earlyNCT01186406
What this trial is testing

Gliadel, XRT, Temodar, Avastin Followed by Avastin, Temodar for Newly Diagnosed Glioblastoma Multiforme (GBM)

Who this might be right for
Glioblastoma MultiformeGliosarcoma
Duke University 41
Large-scale testing (Phase 3)Study completedNCT01450449
What this trial is testing

Short Course vs. Standard Course Radiotherapy in Elderly and/or Frail Patients With Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
International Atomic Energy Agency 115
Early research (Phase 1)UnknownNCT01107522
What this trial is testing

Safety and Tolerability of Carboxyamidotriazole Orotate (CTO) in Solid Tumors or With Temodar® in Glioblastoma or Other Recurrent Malignant Gliomas or in Combination With Temodar® and Radiation Therapy for Patients With Newly Diagnosed Glioblastoma and Malignant Gliomas

Who this might be right for
Solid Tumors, Glioblastoma, Recurrent Malignant Gliomas
Tactical Therapeutics, Inc. 100
Testing effectiveness (Phase 2)Study completedNCT00004146
What this trial is testing

Carboxyamidotriazole + RT in Treating Patients Newly Diagnosed Supratentorial GBM

Who this might be right for
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma
National Cancer Institute (NCI) 55
Next Page